Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Reactive Arthritis

Robert D. Inman, MD  |  Issue: October 2010  |  October 1, 2010

My foes are ever near me Around me and within.
—
J. E. Bode

Infectious Beginnings

In the canonical medical textbook of his day, Sir William Osler, MD, a founder of modern medicine at McGill, Johns Hopkins, and Oxford Universities, provided the following comment: “In recent years, the view that arthritis has an infectious cause has been gaining ground, although as yet positive bacteriological evidence is lacking. No consistent association with any organism has been proved” (Principles and Practice of Medicine, 3rd Edition, 1898). This state-of-the-art conclusion was influenced by the changing concepts of infectious disease at that time. Louis Pasteur’s insights into the microbial world had set the stage for advances in microbiology by the great German scientist Robert Koch, MD, winner of the Nobel Prize in 1905. Within two years of his arrival in Berlin, Dr. Koch began to use a recent technical advance, the Petri dish, named after its inventor, his assistant Julius Petri.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

With the new microbiological techniques, Dr. Koch went in search of the bacterium causing tuberculosis, which at that time was the cause of one in seven deaths in Europe. At a meeting of the Physiological Society of Berlin on March 24, 1882, he announced that he had isolated and grown the tubercle bacillus. Dr. Koch postulated four basic prerequisites for proof that a microorganism causes a disease:

  1. The organism could be isolated in every case of the disease;
  2. It could be cultivated in pure culture;
  3. Cultured organisms could induce the disease in experimental animals; and
  4. The organism could be recovered from the infected experimental animals.

These principles set the bar high, to this day, in demonstrating causality in the infection–arthritis interface.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

At the same time, Ilya Metchnikoff had established a private laboratory at Messina, Italy, to study comparative embryology. There he discovered the phenomenon of phagocytosis after experimenting on the larvae of starfish. His theory—that specific white blood cells could engulf and destroy harmful pathogens such as bacteria—was met with skepticism from leading specialists, including Pasteur. Nonetheless, the conceptual door was opened to recognizing that the outcome of infection was not solely the domain of the invader, but very much dependent on the strength of host defenses, epitomized by the macrophage. The battle lines were drawn for defence of the host. For an astute observer of disease like Osler, it was not a stretch to imagine that arthritis, like meningitis or cellulitis, would turn out to be infectious in origin.

Figure 1: Gene–environment interaction in reactive arthritis
click for large version

Self, Streptococcus, and Immunity

In 1949, Sir Frank Burnet borrowing a concept well established in psychology by Freud and Jung, first used the term “self” in the context of immunology. With this foundational principle, Burnet proposed in 1955 that the fundamental role of the immune system is to discriminate between self and nonself. With the clonal selection theory, he operationalized this concept to argue that protein determinants, which are regarded as foreign by the immune system, can lead to an expansion of immunocompetent cells with specificity for the antigen. Burnet was awarded the Nobel Prize in Medicine and Physiology in 1960.

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:Clinical Criteria/GuidelinesConditions Tagged with:ImmunityInfectionReactive arthritis

Related Articles
    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    July 13, 2016

    The mechanistic link between human leukocyte antigen B27 (HLA-B27) and ankylosing spondylitis (AS) is one of the great enigmas in rheumatology. The introduction of biological therapies that target tumor necrosis factor (TNF) or the interleukin (IL) 23/IL-17A axis has had a major impact on the quality of life for many patients with AS, and one…

    Fellow’s Forum Case Report: Arthritis, Fever, and Weight Loss In a Teenager Suggest A Rheumatic Condition

    January 1, 2014

    Joint pain and swelling flare up in a 14-year-old boy who tests positive for inflammation, thrombocytosis, and human leukocyte antigen B27

    Conformational Flexibility in HLA-B27 Provides Clues to Development of Ankylosing Spondylitis

    July 11, 2016

    Understanding how human leukocyte antigen (HLA) class I molecule B27 promotes spondyloarthritis has intrigued researchers for four decades. Although the association between the single gene variant HLA-B27—specifically some of its subtypes—with ankylosing spondylitis (AS) is particularly strong, how HLA-B27 directly influences disease development has not yet been clearly explained, although hypotheses continue to be generated….

    Data Accumulate to Suggest HLA-B27 Status May Drive Axial Phenotype in SpA

    May 20, 2022

    HLA-B27 may be a phenotypic expression of axial spondyloarthritis (SpA), according to a large international study. The study found patients with axial SpA who were positive for HLA-B27 had more severe radiographic damage than those who were negative for HLA-B27, and three quarters of study patients with ankylosis spondyloarthritis were HLA-B27 positive.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences